Department:Department of Immunology
Research direction:Molecular Oncology
Personal Profile
Graduated from South China University of Technology with a bachelor's degree from 2004 to 2008, and obtained a doctorate degree from the School of Basic Medical Sciences, Sun Yat-sen University from 2008 to 2013. Promoted to a professor at the School of Basic Medical Sciences, Sun Yat-sen University in January 2020. As a corresponding author or co-first author, he has published multiple papers in Nature Cell Biology, The Journal of Clinical Investigation, Nature Communications (two papers), Science Advances, Cancer Research (two papers), Journal of Biological Chemistry and Cell Bioscience, etc. The total number of citations of his papers is more than 560 times, and the highest number of citations for a single paper is more than 260 times. One of his papers has been selected as an ESI highly cited paper. His research achievements have won the First Prize of Guangdong Province Natural Science Award (the second contributor) and the First Prize of the Natural Science Award of the Ministry of Education (the sixth contributor).
In recent years, he has presided over or undertaken the National Science Foundation for Distinguished Young Scholars, two General Program projects of the National Natural Science Foundation of China, a Youth Special Project of the National Key Research and Development Program, the Distinguished Young Scholars Program of the Natural Science Foundation of Guangdong Province, the Pearl River Science and Technology Nova Special Project of Guangzhou, and the "Guangdong Special Support Program" for Young Talents in the Project of Hundred, Thousand and Ten Thousand Talents. His research direction focuses on the interaction between inflammatory signaling pathways in the tumor microenvironment and tumor cells. Starting from the research on the mechanism of imbalance in key inflammatory signaling networks, he aims to find key regulatory factors in the process of tumor occurrence and development, providing important target sites and new therapeutic approaches for tumor prediction, diagnosis and drug development.